These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23266251)

  • 1. C-reactive protein and atherothrombosis: Cause or effect?
    Grad E; Danenberg HD
    Blood Rev; 2013 Jan; 27(1):23-9. PubMed ID: 23266251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits.
    Lu XT; Liu YF; Zhang L; Yang RX; Liu XQ; Yan FF; Wang YB; Bai WW; Zhao YX; Jiang F
    Psychosom Med; 2012; 74(6):604-11. PubMed ID: 22753638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
    Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ
    Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere.
    Nordestgaard BG
    Curr Opin Lipidol; 2009 Oct; 20(5):393-401. PubMed ID: 19667982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Reactive Protein in Atherothrombosis and Angiogenesis.
    Badimon L; Peña E; Arderiu G; Padró T; Slevin M; Vilahur G; Chiva-Blanch G
    Front Immunol; 2018; 9():430. PubMed ID: 29552019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells.
    Suh W; Kim KL; Choi JH; Lee YS; Lee JY; Kim JM; Jang HS; Shin IS; Lee JS; Byun J; Jeon ES; Kim DK
    Biochem Biophys Res Commun; 2004 Aug; 321(1):65-71. PubMed ID: 15358216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
    Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
    Kang DH; Park SK; Lee IK; Johnson RJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring.
    Koole D; Heyligers J; Moll FL; Pasterkamp G
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):635-9. PubMed ID: 22955205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products.
    Chen J; Jin J; Song M; Dong H; Zhao G; Huang L
    Gene; 2012 Apr; 496(2):128-35. PubMed ID: 22301267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.
    Andrews KL; Moore XL; Chin-Dusting JP
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):736-42. PubMed ID: 20374256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein comes of age.
    Verma S; Szmitko PE; Ridker PM
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):29-36; quiz 58. PubMed ID: 16265340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
    Herman AG
    Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.